INNATE PHARMA (EPA:IPH) | WebDisclosure

Basculer en Français

8621	Companies
142891	Keywords
78626	Articles
76348	Press releases

Home
Companies
INNATE PHARMA

BRIEF

published on 01/27/2025 at 07:05, 2 months 24 days ago

Innate Pharma lance une étude de phase 1 sur IPH4502 dans les tumeurs solides avancées

Innate Pharma Essai De Phase 1 IPH4502 Nectine-4 Tumeurs Solides Avancées
PRESS RELEASE

published on 01/27/2025 at 07:00, 2 months 24 days ago

Inside Information / Other news releases
Innate Pharma announces first patient dosed in Phase 1 study of Nectin-4 targeting Antibody Drug IPH4502 in advanced solid tumors. Innovative ADC for multiple cancer types

Innate Pharma Phase 1 Study IPH4502 Topoisomerase I Inhibitor Antibody Drug Conjugate
PRESS RELEASE

published on 01/27/2025 at 07:00, 2 months 24 days ago

Informations privilégiées / Autres communiqués
Innate Pharma annonce le traitement du premier patient dans l'essai de phase 1 évaluant IPH4502, son conjugué anticorps-médicament ciblant Nectine-4, dans une sélection de tumeurs solides avancées

Innate Pharma Tumeurs Solides Conjugué Anticorps-médicament IPH4502 Nectine-4
BRIEF

published on 01/16/2025 at 07:05, 3 months 4 days ago

New Share and Voting Rights Report for Innate Pharma

Common Shares Voting Rights AMF Shareholding Structure Innate Pharma
BRIEF

published on 01/16/2025 at 07:05, 3 months 4 days ago

Nouveau Bilan des Actions et Droits de Vote pour Innate Pharma

Droits De Vote AMF Actions Ordinaires Structure Actionnariale Innate Pharma
PRESS RELEASE

published on 01/16/2025 at 07:00, 3 months 4 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Innate Pharma releases shares and voting rights update as of December 31, 2024, in compliance with regulations. Learn more about the global biotech company's innovative immunotherapies for cancer patients

Voting Rights Shares Biotechnology Immunotherapy Innate Pharma
PRESS RELEASE

published on 01/16/2025 at 07:00, 3 months 4 days ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Innate Pharma publie le nouveau nombre d'actions et de droits de vote au 31 décembre 2024 conformément à la réglementation financière. Détails sur son capital social et ses projets d'immunothérapie contre le cancer

Droits De Vote Actions Immunothérapie Cancer Innate Pharma
BRIEF

published on 12/20/2024 at 07:05, 4 months ago

Innate Pharma à la 43ème J.P. Morgan Healthcare Conference

Investisseurs Présentation En Direct Immunothérapie Innate Pharma J.P. Morgan Conference
BRIEF

published on 12/20/2024 at 07:05, 4 months ago

Innate Pharma at the 43rd JP Morgan Healthcare Conference

Investors Immunotherapy Innate Pharma JP Morgan Conference Live Presentation
PRESS RELEASE

published on 12/20/2024 at 07:00, 4 months ago

Informations privilégiées / Autres communiqués
Innate Pharma annonce sa participation à la 43ème J.P. Morgan Healthcare Conference avec présentations de ses dirigeants. Focus sur les traitements d'immunothérapies contre le cancer

Cancer Innate Pharma Biotechnologies Immunothérapies J.P. Morgan Healthcare Conference

Accesswire

Published on 04/18/2025 at 23:35, 2 days 4 hours ago

urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Published on 04/18/2025 at 01:20, 3 days 2 hours ago

Aston Bay Files Technical Report for Storm Copper Project Initial Mineral Resource Estimate
Published on 04/18/2025 at 00:42, 3 days 3 hours ago

Regency Silver Announces New CEO
Published on 04/18/2025 at 00:00, 3 days 4 hours ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Published on 04/17/2025 at 23:50, 3 days 4 hours ago

Fourth Quarter and Year-End 2024 Results

View all ACCESSWIRE

EQS Group

Published on 04/18/2025 at 18:00, 2 days 10 hours ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25.
Published on 04/18/2025 at 18:00, 2 days 10 hours ago

E-PANGO: Résultats annuels 2024
Published on 04/18/2025 at 17:54, 2 days 10 hours ago

VALBIOTIS SA: Compte-rendu de l’Assemblée générale mixte du 18 avril 2025
Published on 04/18/2025 at 17:52, 2 days 10 hours ago

Market entry in France – Cicor acquires significant business activities of Éolane
Published on 04/18/2025 at 17:45, 2 days 10 hours ago

Linedata Services: Déclaration des transactions sur actions propres opération du 16 avril 2025

Les Echos

Published on 04/18/2025 at 17:45, 2 days 10 hours ago

Saint-Gobain once again featured on CDP’s “Climate A List”
Published on 04/18/2025 at 17:45, 2 days 10 hours ago

Saint-Gobain figure une nouvelle fois sur la « Climate A List » établie par le CDP
Published on 04/18/2025 at 11:16, 2 days 16 hours ago

Déclaration hebdomadaire d'opérations effectuées du 14 au 17 avril 2025
Published on 04/18/2025 at 11:16, 2 days 16 hours ago

Disclosure of transactions in own shares from April 14 to April 17, 2025
Published on 04/18/2025 at 07:00, 2 days 21 hours ago

Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders

View all LES ECHOS COMFI WIRE